Daniel K. Spiegelman

Daniel K. Spiegelman

DirectoratMyriad Genetics· In proxies 2023–2024

Daniel K. Spiegelman sits on 2 public boards.

Experience

  1. Myriad GeneticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -57%
  2. Maze TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  3. Tizona Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?